182 related articles for article (PubMed ID: 18206679)
21. Solvent neurotoxicity.
Dick FD
Occup Environ Med; 2006 Mar; 63(3):221-6, 179. PubMed ID: 16497867
[No Abstract] [Full Text] [Related]
22. Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA; Cavaletti G; Bruna J; Kyritsis AP; Kalofonos HP
Arch Toxicol; 2014 Sep; 88(9):1669-79. PubMed ID: 25069804
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced movement disorders.
Rodnitzky RL
Clin Neuropharmacol; 2002; 25(3):142-52. PubMed ID: 12023568
[No Abstract] [Full Text] [Related]
24. Adult versus developmental neurotoxicology: an occupational perspective of similarities and differences.
Nelson BK
Neurotoxicol Teratol; 1994; 16(2):213-8. PubMed ID: 8052196
[TBL] [Abstract][Full Text] [Related]
25. The first 83 and the next 83: perspectives on neurotoxicology.
Weiss B
Neurotoxicology; 2009 Sep; 30(5):832-50. PubMed ID: 19822264
[TBL] [Abstract][Full Text] [Related]
26. A brief review of cognitive assessment in neurotoxicology.
Han DY; Hoelzle JB; Dennis BC; Hoffmann M
Neurol Clin; 2011 Aug; 29(3):581-90. PubMed ID: 21803211
[TBL] [Abstract][Full Text] [Related]
27. Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotection.
Slikker W; Xu Z; Wang C
Ann N Y Acad Sci; 2005 Aug; 1053():309-10. PubMed ID: 16179536
[No Abstract] [Full Text] [Related]
28. The World Federation of Neurology and the challenges in Environment Neurology.
Reis J; Grisold W; Öztürk Ş; Wasay M; Román GC; Carroll WM
Rev Neurol (Paris); 2019 Dec; 175(10):742-744. PubMed ID: 31540677
[TBL] [Abstract][Full Text] [Related]
29. Overview of neurotoxicology.
Tilson HA
Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.1. PubMed ID: 20957638
[TBL] [Abstract][Full Text] [Related]
30. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity.
Park SB; Alberti P; Kolb NA; Gewandter JS; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S13-S25. PubMed ID: 31647154
[TBL] [Abstract][Full Text] [Related]
31. Introduction: A coming of age for molecular neurotoxicology.
Verity MA
Brain Pathol; 2002 Oct; 12(4):472-4. PubMed ID: 12408233
[No Abstract] [Full Text] [Related]
32. Toxin-Induced Neuropathies.
Toledano M
Neurol Clin; 2020 Nov; 38(4):749-763. PubMed ID: 33040859
[TBL] [Abstract][Full Text] [Related]
33. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
34. Reconsideration of the WHO NCTB strategy and test selection.
Anger WK
Neurotoxicology; 2014 Dec; 45():224-31. PubMed ID: 25172409
[TBL] [Abstract][Full Text] [Related]
35. Environmental Neurology Research Group (ENRG) of the World Federation of Neurology (WFN).
Prockop LD
J Neurol Sci; 2007 Nov; 262(1-2):2. PubMed ID: 17617423
[No Abstract] [Full Text] [Related]
36. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2004 Dec; 24(4):419-26. PubMed ID: 15637653
[TBL] [Abstract][Full Text] [Related]
37. Developmental neurotoxicity. Illustration of principles.
Bearer CF
Pediatr Clin North Am; 2001 Oct; 48(5):1199-213, ix. PubMed ID: 11579669
[TBL] [Abstract][Full Text] [Related]
38. Environmental Neurology has become a hot topic.
Reis J; Béjot Y; Giroud M; Spencer P
Rev Neurol (Paris); 2019 Dec; 175(10):579-580. PubMed ID: 31611008
[No Abstract] [Full Text] [Related]
39. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.
Kieseier BC; Kiefer R; Gold R; Hemmer B; Willison HJ; Hartung HP
Muscle Nerve; 2004 Aug; 30(2):131-56. PubMed ID: 15266629
[TBL] [Abstract][Full Text] [Related]
40. Twenty-fourth International Neurotoxicology Conference "Environmental Etiologies of Neurological Disorders: Modifiers of Risk".
Cranmer JM
Neurotoxicology; 2008 Sep; 29(5):753-4. PubMed ID: 18789965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
